Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoringÁgueda Molinos-Quintana, Josè Antonio Pérez-Simón, Anna Alonso‐Saladrigues et al.|Frontiers in Immunology|2024Cited by 21
Comparison of pneumonia features in children caused by SARS‐CoV‐2 and other viral respiratory pathogensRut Del Valle, Alfredo Tagarro, Álvaro Ballesteros et al.|Pediatric Pulmonology|2022Cited by 6
Abstract P3-01-04: A real-world evidence study of everolimus plus endocrine therapy beyond CDK4/6 inhibitors for HR+/HER2- advanced breast cancerRodrigo Sánchez-Bayona, Eva Ciruelos, Isabel Echavarría et al.|Cancer Research|2023Cited by 1
Corrigendum: Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoringÁgueda Molinos-Quintana, Josè Antonio Pérez-Simón, Blanca Herrero et al.|Frontiers in Immunology|2024Cited by 1
Comparison of pneumonia features in children caused by SARS-CoV-2 and other viral respiratory pathogens.Rut Del Valle, Alfredo Tagarro, Álvaro Ballesteros et al.|Unknown|2021Cited by 0